- Home
- VNDA vs RZLT Comparison
VNDA vs RZLT Comparison
Compare VNDA & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- RZLT
- Stock Information
- Founded
- VNDA 2002
- RZLT 2010
- Country
- VNDA United States
- RZLT United States
- Employees
- VNDA N/A
- RZLT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- VNDA Health Care
- RZLT Health Care
- Exchange
- VNDA Nasdaq
- RZLT Nasdaq
- Market Cap
- VNDA 270.0M
- RZLT 292.0M
- IPO Year
- VNDA 2006
- RZLT N/A
- Fundamental
- Price
- VNDA $4.51
- RZLT $4.92
- Analyst Decision
- VNDA Strong Buy
- RZLT Strong Buy
- Analyst Count
- VNDA 2
- RZLT 8
- Target Price
- VNDA $15.50
- RZLT $11.63
- AVG Volume (30 Days)
- VNDA 499.8K
- RZLT 336.6K
- Earning Date
- VNDA 02-05-2025
- RZLT 02-11-2025
- Dividend Yield
- VNDA N/A
- RZLT N/A
- EPS Growth
- VNDA N/A
- RZLT N/A
- EPS
- VNDA N/A
- RZLT N/A
- Revenue
- VNDA $190,858,000.00
- RZLT N/A
- Revenue This Year
- VNDA $5.60
- RZLT N/A
- Revenue Next Year
- VNDA $42.85
- RZLT N/A
- P/E Ratio
- VNDA N/A
- RZLT N/A
- Revenue Growth
- VNDA N/A
- RZLT N/A
- 52 Week Low
- VNDA $3.46
- RZLT $0.92
- 52 Week High
- VNDA $6.75
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- VNDA 42.95
- RZLT 50.84
- Support Level
- VNDA $4.77
- RZLT $4.47
- Resistance Level
- VNDA $4.95
- RZLT $4.98
- Average True Range (ATR)
- VNDA 0.15
- RZLT 0.32
- MACD
- VNDA -0.03
- RZLT -0.01
- Stochastic Oscillator
- VNDA 31.82
- RZLT 42.86
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.